Scilex Holding Co. (SCLX) Stock Price, Quote & News

Company Profile

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 650 516 4310

Website: www.scilexholding.com

Address:

960 San Antonio Road, Palo Alto, United States

PatientiaSitVirtus Jun. 9 at 1:17 AM

$SCLX Link to source for all you fine people: https://www.sec.gov/Archives/edgar/data/1820190/000119312526253831/d279959ds3.htm

0 · Reply

TheToaster Jun. 8 at 11:18 PM

$SCLX i think this offering is the last cash grab before the curtains close.

0 · Reply

PatientiaSitVirtus Jun. 8 at 9:42 PM

$SCLX Food for thought 🍖 🤔 “As of May 15, 2026, Scilex Holding Company (SCLX) had 8.49 million total outstanding shares.” “The recalculated total for SCLX brings outstanding shares to approximately 17.15 million and fully diluted shares to 17.64 million, including the 6.58 million selling holder shares, 2.08 million new shares, and 490,617 warrants.”

0 · Reply

PatientiaSitVirtus Jun. 8 at 7:56 PM

$SCLX It’s very interesting to me that no one is talking about the news from last week. Ji more than doubled the share count with new share offerings (aka dilution) the day after he issued the Semnur dividend (June 2). He obviously only dangled the Semnur dividend like a fishing lure to attract as much new blood as possible just so he could slaughter them with dilution the very next day. Ji is pure evil. He’s always trying to trick investors. Are y’all not talking about it in hopes of keeping it secret or because y’all didn’t know and just got caught with your pants down? Either way, shares are now worth less than 50% of today’s $7 share price thanks to the new massive dilution. Plan accordingly.

0 · Reply

BioCEOsSukk Jun. 8 at 3:13 PM

$SCLX $SRNE Be vewwy vewwy quiet, wewwe hunting showwts...

2 · Reply

Sacsofcash Jun. 7 at 10:24 PM

$SRNE $SCLX

0 · Reply

Sacsofcash Jun. 7 at 3:37 PM

$SCLX

2 · Reply

TheToaster Jun. 6 at 12:41 AM

$SCLX hahahahahahahahahahaha I thought, so you buy 1 share of SCLX and get 1 share of SMNR...seems like a good deal. Except you cant just keep the share of SMNR. I guess you could short it using your dividend to cover as a way of securimg that value. But i went and looked at what SMNR is trading at. $4.95.... not too bad. Then i looked at the bid and the ask. I knew it wasnt gonna be too close. It doesnt have the liquidity. I know that.... And then i looked at rhe volume!!!!! Bwahahahahahahaha....1 fucking share!!! This pile of dogshit traded 1 share!!!!! I had to dbl check Schwab but they didn't give any volume and couldnt display a chart for today. Lol 😆 Even $SRNE has better liquidity than SMNR.

1 · Reply

BioCEOsSukk Jun. 5 at 7:28 PM

$SRNE $SCLX It's comin my duckies! Look at hod and volume!!!

1 · Reply

Headinghigher Jun. 5 at 2:06 PM

$SCLX $SRNE anything shaking with a possible SRNE rebound post BK proceedings? Thx

2 · Reply

Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

2026-06-02T21:15:49.000Z - 6 days ago

Scilex files to sell 2.08M shares of common stock

2026-06-02T21:15:10.000Z - 6 days ago

Scilex files to sell 6.58M shares of common stock for holders

Jun 2, 2026, 8:00 AM EDT - 6 days ago

Scilex Holding Company Registration statement: Registration filing

2026-05-22T17:26:30.000Z - 17 days ago

Scilex approves dividend of Semnur Pharmaceuticals shares

May 22, 2026, 1:15 PM EDT - 17 days ago

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

May 20, 2026, 8:00 AM EDT - 19 days ago

Scilex Holding Company Quarterly report: Q1 2026

2026-05-05T17:11:44.000Z - 4 weeks ago

Scilex’s ACEA Thera, ACEA Pharma enter definitive agreement with Phoenix Asia

PHOE

May 5, 2026, 1:00 PM EDT - 4 weeks ago

Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited

May 5, 2026, 8:00 AM EDT - 4 weeks ago

Scilex Holding Company Proxy statement: Proxy filing

May 4, 2026, 6:00 AM EDT - 5 weeks ago

Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Scilex Holding Company Proxy statement: Proxy filing

2026-04-27T21:51:43.000Z - 6 weeks ago

Datavault to receive $120M cash contribution from Scilex

DVLT

Apr 27, 2026, 5:40 PM EDT - 6 weeks ago

Datavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum Platform

DVLT

2026-04-27T12:54:27.000Z - 6 weeks ago

Datavault executes term sheet for $120M cash contribution from Scilex

DVLT

Apr 20, 2026, 9:00 AM EDT - 7 weeks ago

Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

2026-04-16T21:15:15.000Z - 7 weeks ago

Scilex files $500M mixed securities shelf

Apr 16, 2026, 8:00 AM EDT - 7 weeks ago

Scilex Holding Company Registration statement: Registration filing

2026-04-13T15:40:24.000Z - 2 months ago

Scilex Holding Co trading resumes

2026-04-13T15:15:09.000Z - 2 months ago

Scilex Holding Co trading halted, volatility trading pause

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Scilex Holding Company Annual report: Q4 2025

2026-03-13T15:30:18.000Z - 3 months ago

Scilex files federal lawsuit alleging unauthorized sale of Datavault shares

DVLT

Feb 5, 2026, 6:00 AM EST - 4 months ago

Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026

DVLT

2026-01-30T14:11:37.000Z - 4 months ago

Scilex announces $20M strategic investment in Quantum Scan

Jan 30, 2026, 9:00 AM EST - 4 months ago

Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets

2026-01-02T14:05:26.000Z - 5 months ago

Scilex appoints Kasowitz LLP as litigation, IP counsel

Jan 2, 2026, 9:00 AM EST - 5 months ago

Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel

2025-12-23T14:05:20.000Z - 5 months ago

Scilex confirms Dream Bowl 2026 Meme Coin claim process

DVLT

Dec 23, 2025, 9:00 AM EST - 5 months ago

Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.

Dec 16, 2025, 7:00 AM EST - 6 months ago

Scilex Holding Company Registration statement: Registration filing

2025-12-16T11:10:48.000Z - 6 months ago

Scilex files to sell 1.7M shares of common stock for holders

Nov 26, 2025, 6:00 AM EST - 6 months ago

Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing Its Two-Tranche Equity Financing in Datavault AI Inc.

Nov 25, 2025, 2:37 PM EST - 6 months ago

Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds

2025-11-24T11:20:44.000Z - 7 months ago

Scilex announces exercise of warrants for $20.3M gross proceeds

Nov 24, 2025, 6:00 AM EST - 7 months ago

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

Nov 21, 2025, 3:59 PM EST - 7 months ago

Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc.

Nov 14, 2025, 7:00 AM EST - 7 months ago

Scilex Holding Company Quarterly report: Q3 2025

Nov 11, 2025, 9:30 AM EST - 7 months ago

Scilex Holding Company Announces that the Board of Directors of Datavault AI Inc. Has Approved the Distribution of a Dream Bowl 2026 Meme Coin to All Eligible Scilex and Datavault AI Stockholders of Record and Set a Record Date of November 25, 2025

2025-11-11T13:35:12.000Z - 7 months ago

Datavault board approves distribution of Dream Bowl Draft meme coin

DVLT

Nov 7, 2025, 7:00 AM EST - 7 months ago

Scilex Holding Company Proxy statement: Proxy filing

2025-11-04T12:46:36.000Z - 7 months ago

Scilex licenses Datavault’s AI technology

DVLT

Nov 4, 2025, 6:00 AM EST - 7 months ago

Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AI

Nov 3, 2025, 9:53 AM EST - 7 months ago

Scilex Holding Company Announces the Sponsorship of Dream Bowl 2026 and Set a Record Date of November 14, 2025 for Its Shareholders to Receive Dream Bowl 2026 Meme Coin Distributed by DataVault AI

Nov 3, 2025, 8:45 AM EST - 7 months ago

Datavault AI Announces Record Date of Nov. 14, 2025, for Dream Bowl Draft Meme Coin Distribution to All Eligible Scilex and Datavault AI Shareholders

DVLT

2025-11-03T13:25:53.000Z - 7 months ago

Datavault announces record date of Nov. 14 for Dream Bowl Draft meme coin

DVLT

Oct 28, 2025, 8:00 AM EDT - 7 months ago

Scilex Holding Company Proxy statement: Proxy filing

Oct 1, 2025, 9:00 AM EDT - 8 months ago

Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase

Sep 26, 2025, 4:12 PM EDT - 9 months ago

Datavault AI Announces Closing of Initial Tranche Investment from Scilex Holding Company

DVLT

Sep 26, 2025, 3:57 PM EDT - 9 months ago

Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI

Sep 25, 2025, 3:45 PM EDT - 9 months ago

Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI

Sep 25, 2025, 6:00 AM EDT - 9 months ago

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bitcoin

Sep 24, 2025, 10:11 AM EDT - 9 months ago

Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management

Sep 23, 2025, 11:12 AM EDT - 9 months ago

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Semnur Common Stock in Exchange for $100 Million in Bitcoin

Sep 23, 2025, 10:00 AM EDT - 9 months ago

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

Sep 23, 2025, 6:00 AM EDT - 9 months ago

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 2025

Sep 22, 2025, 3:49 PM EDT - 9 months ago

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination

Sep 4, 2025, 9:00 AM EDT - 9 months ago

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali's Shareholders of the Previously Announced Business Combination

Aug 21, 2025, 6:00 AM EDT - 10 months ago

Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share and Jaisim Shah, Scilex's CEO and President, Will be Dedicated to Semnur on a Full Time Basis to Rapidly Advance SP-102 to Regulatory Approval and Commercialization for the Treatment of Lumbosacral Radicular Pain (LRP)/Sciatica

Aug 13, 2025, 8:00 AM EDT - 10 months ago

Scilex Holding Company Quarterly report: Q2 2025

Aug 13, 2025, 6:00 AM EDT - 10 months ago

Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

Aug 4, 2025, 8:00 AM EDT - 11 months ago

Scilex Holding Company Registration statement: Registration filing

Jun 23, 2025, 4:50 PM EDT - 1 year ago

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a future date to be determined by the Board

Jun 5, 2025, 12:05 PM EDT - 1 year ago

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal

May 16, 2025, 9:00 AM EDT - 1 year ago

Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL

May 16, 2025, 8:00 AM EDT - 1 year ago

Scilex Holding Company Proxy statement: Proxy filing

May 14, 2025, 8:00 AM EDT - 1 year ago

Scilex Holding Company Quarterly report: Q1 2025

May 1, 2025, 9:00 AM EDT - 1 year ago

Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.

Apr 30, 2025, 1:46 PM EDT - 1 year ago

Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule

Apr 22, 2025, 9:00 AM EDT - 1 year ago

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025 to May 2, 2025

Apr 16, 2025, 2:12 PM EDT - 1 year ago

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

Apr 15, 2025, 9:00 AM EDT - 1 year ago

Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada's Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®'s Acute Treatment of Migraine With or Without Aura in Canada

Apr 11, 2025, 9:00 AM EDT - 1 year ago

Scilex Holding Company Announces 1-for-35 Reverse Stock Split

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Scilex Holding Company Annual report: Q4 2024

Mar 26, 2025, 8:24 PM EDT - 1 year ago

Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025

Feb 27, 2025, 7:00 AM EST - 1 year ago

Scilex Holding Company Proxy statement: Proxy filing

Feb 26, 2025, 7:00 AM EST - 1 year ago

Scilex Holding Company Proxy statement: Proxy filing

Feb 14, 2025, 7:00 AM EST - 1 year ago

Scilex Holding Company Proxy statement: Proxy filing

Jan 31, 2025, 9:00 AM EST - 1 year ago

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

Jan 21, 2025, 11:49 AM EST - 1 year ago

Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)

Jan 21, 2025, 9:46 AM EST - 1 year ago

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

Jan 21, 2025, 9:00 AM EST - 1 year ago

Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC

Jan 21, 2025, 6:00 AM EST - 1 year ago

Scilex Holding Company Announces Filing of its Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2024

Jan 17, 2025, 7:00 AM EST - 1 year ago

Scilex Holding Company Quarterly report: Q3 2024

Jan 16, 2025, 3:38 PM EST - 1 year ago

Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adults

Dec 30, 2024, 9:00 AM EST - 1 year ago

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from November 7, 2024 to January 28, 2025

Dec 13, 2024, 12:23 PM EST - 1 year ago

Scilex Holding Company Announces Closing of $17 Million Registered Direct Offering

PatientiaSitVirtus Jun. 9 at 1:17 AM

$SCLX Link to source for all you fine people: https://www.sec.gov/Archives/edgar/data/1820190/000119312526253831/d279959ds3.htm

0 · Reply

TheToaster Jun. 8 at 11:18 PM

$SCLX i think this offering is the last cash grab before the curtains close.

0 · Reply

PatientiaSitVirtus Jun. 8 at 9:42 PM

0 · Reply

PatientiaSitVirtus Jun. 8 at 7:56 PM

0 · Reply

BioCEOsSukk Jun. 8 at 3:13 PM

$SCLX $SRNE Be vewwy vewwy quiet, wewwe hunting showwts...

2 · Reply

Sacsofcash Jun. 7 at 10:24 PM

$SRNE $SCLX

0 · Reply

Sacsofcash Jun. 7 at 3:37 PM

$SCLX

2 · Reply

TheToaster Jun. 6 at 12:41 AM

1 · Reply

BioCEOsSukk Jun. 5 at 7:28 PM

$SRNE $SCLX It's comin my duckies! Look at hod and volume!!!

1 · Reply

Headinghigher Jun. 5 at 2:06 PM

$SCLX $SRNE anything shaking with a possible SRNE rebound post BK proceedings? Thx

2 · Reply

Skunky Jun. 5 at 1:03 PM

$SCLX I bought shares before the June 1 record date AND after it. What's interesting is my June 1 and June 4 purchases are both labeled: "SCILEX HLDG CO TRADES WITH DUE BILLS"

1 · Reply

TheToaster Jun. 5 at 11:52 AM

$SCLX my guess is Ji stripped any drugs worth value from Acea, leveraged the peoperty and plant, pocketed the cash via salary or bonus, then sold it to SCLX to get more cash. Thats the Ji i know. Theres no way he placed a legit asset into SCLX that is millions upon millions in debt. Thats like renovating your house as the bank begins the foreclosure process. Just ask @Sacsofcash . Besides, he already has proven manufacturing capacity w Lenovo/Concortis/Bioserve. So Acea is possibly redundant and a weight. If its too confusing and rife w whatifs and unknowns, thats by design. That the key. The peak behind the curtains.

0 · Reply

Tight_grapes Jun. 4 at 7:25 PM

$SCLX Is there an undisclosed relationship between Semnur and Acea? That would certainly be an upside surprise, but I obviously would only believe when I saw it in a legally binding SEC filed docment, not a fishy PR. I guess we'll see...

1 · Reply

TheToaster Jun. 4 at 5:50 PM

$SCLX the value of SMNR exceeds SCLX. At least on paper. If the dividends rrade w the shares, then a clawback would be easy enough. Whoever has a share of SCLX has a share of SMNR.... where it qould get muddy if Ji hits the ATM and sells a bunch of SCLX shares that dont have a dividend attached to them. I hand it to Ji, he might end up being the very catalyst for shares to be traded via block chain .

0 · Reply

BioCEOsSukk Jun. 4 at 2:37 PM

$SCLX Acea divestiture, Semnur dividend pay date announced on same day HSR clearance IF Scilex filed HSR May 4 - which also unlocks NASDAQ round lot requirement for uplisting, etc... Feels like Ji and Ma aren't driving the Uber Limo anymore. So who is...

0 · Reply

Skunky Jun. 4 at 1:41 PM

$SCLX I asked ChatGPT to guess the EX-date: If I had to make a prediction today, based on Nasdaq's treatment of large stock dividends and spin-offs, I'd lean toward: Ex-dividend date = June 16, 2026 (the first trading day after the June 15 payment date). Why? The Semnur distribution is large relative to SCLX's market value. Nasdaq often uses due-bill procedures for large distributions. Under due-bill treatment, the dividend rights stay attached to the shares through the payment date. The stock then begins trading ex-distribution on the first trading day after payment. That would fit the language in the Scilex press release and explain why Nasdaq hasn't simply said "June 2 is the ex-date."

1 · Reply

Skunky Jun. 4 at 1:06 PM

$SCLX https://www.globenewswire.com/news-release/2026/06/04/3306806/0/en/scilex-holding-company-scilex-announces-a-payment-date-of-june-15-2026-for-the-previously-announced-dividend-of-semnur-pharmaceuticals-inc-common-stock-to-holders-of-scilex-common-.html

0 · Reply

Skunky Jun. 4 at 1:05 PM

$SCLX 🚨 Payment date confirmed: June 15, 2026. Record date: June 1, 2026. Most important line in the PR: "Nasdaq will determine the ex-dividend date in accordance with its rules." Until Nasdaq announces the ex-date, anyone claiming they know exactly how the dividend rights transfer is guessing. 👀

0 · Reply

Awaywithshorts Jun. 4 at 12:57 PM

$SCLX Confident

0 · Reply

Skunky Jun. 4 at 10:50 AM

$SCLX Court update: Defendants just filed a Motion to Compel Arbitration in the Marc Wade/St. James case. It's an attempt to move the dispute out of federal court and into arbitration. Hearing set for Aug. 17, 2026. 👀⚖️

0 · Reply

Himbhas18 Jun. 3 at 9:42 PM

$DVLT so much red tape with VIVASOR and $SCLX need them to sell all of it before it starts back up. Probably RS will clean up the structure

1 · Reply

Skunky Jun. 3 at 2:07 PM

$DVLT $SCLX $SRNE Shareholders continue to get terrible deals from Vivasor.

0 · Reply

Market Cap	59.44M
Revenue (ttm)	30.25M
Net Income (ttm)	-358.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,185.88%
Debt to Equity Ratio	-0.32

Volume	42,100
Avg Vol	84,598
Day's Range	N/A - N/A
Shares Out	8.49M
Stochastic %K	22%
Beta	1.70
Analysts	Hold
Price Target	$367.13